Liang and his colleagues showed that an analog of erastin augmented cisplatin effects against non-small cell lung cancer cells by inducing ferroptosis detected by upregulation of ROS, and lipid peroxidation in addition to downregulated GPX4, the key regulator of ferroptosis inhibition7,52. This evidence concerns the gene GPX4 and non-small cell lung carcinoma.